Thanh bên bài viết

PDF
Ngày xuất bản: 25/11/2024
Số lượt xem tóm tắt: 37
Số lượt xem PDF: 9
DOI: https://doi.org/10.59873/vjid.v4i48.418
Số xuất bản
Tập 4 Số 48 (2024)
Chuyên mục
Nghiên cứu khoa học
Trích dẫn bài báo
Dao, T. N. L., Nguyen, V. H., & Duong, H. Q. (2024). PREVALENCE OF ASPERGILLUS FUMIGATUS ISOLATED FROM PATIENTS INDICATED FOR PATHOGENIC FUNGAL TESTING AT THE NATIONAL LUNG HOSPITAL IN 2023. Tạp chí Truyền nhiễm Việt Nam, 4(48). https://doi.org/10.59873/vjid.v4i48.418

PREVALENCE OF ASPERGILLUS FUMIGATUS ISOLATED FROM PATIENTS INDICATED FOR PATHOGENIC FUNGAL TESTING AT THE NATIONAL LUNG HOSPITAL IN 2023

Dao Thi Ngoc Lan1,, Nguyen Van Hung1, Duong Hong Quan2
1 National Lung Hospital
2 Hanoi University of Public Health

Nội dung chính của bài viết

Tóm tắt

Objectives: To describe the prevalence of Aspergillus fumigatus (A. fumigatus) infection in patients indicated for pathogenic fungal testing at the National Lung Hospital in 2023.
Subjects and methods: Patients are assigned to undergo fungal testing at the National Lung Hospital in 2023. Cross-sectional descriptive study.
Results and conclusions: Of the 26,301 patients who were indicated for fungal testing, 817 (3.11%) of patients had positive fungal culture and identification results for A. fumigatus. Of which, 787 (96.33%) patients were only infected with A. fumigatus and 30 (3.67%) cases were co-infected with A. fumigatus with another fungal species. The proportion of men dominated 83.48%, women accounted for 16.52%. The median age of the patients was 65.19 ± 12.92. In which, the age group from 61 - 80 accounts for the largest proportion with 63.28%. The isolation rate of A. fumigatus in sputum specimens was mainly (71.4%), followed by bronchial fluid (25.4%), and other specimens accounted for a small proportion (< 1%). The isolation rate of A. fumigatus fungi in the departments of the National Lung Hospital was mainly found in the Respiratory Department (24.3%), ranked second in the Emergency Department (17.3%).

Chi tiết bài viết

Từ khóa

Aspergillus fumigatus (A. fumigatus), Prevalence, fungal test, Aspergillus, National Lung Hospital

Tài liệu tham khảo

1. Bradley K, Le-Mahajan A, Morris B, Peritz T, Chiller T, Forsberg K, et al. Fatal FungicideAssociated Triazole-Resistant Aspergillus fumigatus Infection, Pennsylvania, USA - Volume 28, Number 9-September 2022 - Emerging Infectious Diseases journal - CDC.
2. Patterson TF, Thompson GR, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis Off Publ Infect Dis Soc Am. 2016 Aug 15; 63(4):e1-60.
3. Baddley JW, Andes DR, Marr KA, Kontoyiannis DP, Alexander BD, Kauffman CA, et al. Factors Associated with Mortality in Transplant Patients with Invasive Aspergillosis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2010 Jun 15; 50(12):1559-67.
4. Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of Direct Healthcare Costs of Fungal Diseases in the United States. Clin Infect Dis Off Publ Infect Dis Soc Am. 2019 May 17; 68(11):1791-7.
5. High TB burden country Profiles.
6. Duong TMN, Le MH, Beardsley J, Denning DW, Le NH, Nguyen BNT. Updated estimation of the burden of fungal disease in Vietnam. Mycoses. 2023 Apr; 66(4):346-53.
7. Hidden Killers: Human Fungal Infections |Science Translational Medicine.
8. Menzin J, Meyers JL, Friedman M, Perfect JR, Langston AA, Danna RP, et al. Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients. Am J Health Syst Pharm. 2009 Oct 1; 66(19):1711-7.
9. Cadena J, Thompson GR, Patterson TF. Invasive Aspergillosis: Current Strategies for Diagnosis and Management. Infect Dis Clin North Am. 2016 Mar; 30(1):125-42.
10. Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children - PMC.
11. Vu Thi Vy. Determination of susceptibility to antifungal drugs of Aspergillus strain isolated in patients with invasive pulmonary fungal infection at Bach Mai Hospital from July 2020 to June 2021. Hanoi Medical University; 2021.
12. Zhang Y, Wang S, Zhou C, Zhang Y, Pan J, Pan B, et al. Epidemiology of Clinically Significant Aspergillus Species from a Large Tertiary Hospital in Shanghai, China, for the Period of Two Years. Infect Drug Resist. 2023; 16:4645-57.
13. Wang Y, Zhang L, Zhou L, Zhang M, Xu Y. Epidemiology, Drug Susceptibility, and Clinical Risk Factors in Patients With Invasive Aspergillosis. Front Public Health. 2022;10:835092.
14. Wang HC, Hsieh MI, Choi PC, Wu WL, Wu CJ, TSARM Hospitals. Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020. Mycoses. 2023 Aug; 66(8):711-22.
15. Tio SY, Chen SCA, Hamilton K, Heath CH, Pradhan A, Morris AJ, et al. Invasive aspergillosis in adult patients in Australia and New Zealand: 2017- 2020. Lancet Reg Health - West Pac.
16. Kiertiburanakul S, Thibbadee C, Santanirand P. Invasive aspergillosis in a tertiary-care hospital in Thailand. J Med Assoc Thail Chotmaihet Thangphaet. 2007 May; 90(5):895-902.
17. Lao M, Zhang K, Zhang M, Wang Q, Li J, Su L, et al. Clinical Features and Co-Infections in Invasive Pulmonary Aspergillosis in Elderly Patients. Infect Drug Resist. 2020; 13:3525-34.
18. Nguyen NTB, Le Ngoc H, Nguyen NV, Dinh LV, Nguyen HV, Nguyen HT, et al. Chronic Pulmonary Aspergillosis Situation among Post Tuberculosis Patients in Vietnam: An Observational Study. J Fungi Basel Switz. 2021 Jun 30; 7(7):532.